We are broadening treatment opportunities for people living with Alzheimer’s disease and mild cognitive impairment through the Memory Clinic.
The clinic now offers infusion therapies using Leqembi and Kisunla, two medications developed to address biological changes associated with Alzheimer’s disease. Research studies have demonstrated that the treatments may help delay worsening memory loss and declines in day-to-day abilities for some individuals diagnosed in the earlier stages of the disease.
Specialists at the clinic work closely with patients and families to determine whether the therapies are appropriate. The process includes neurological evaluations, brain imaging, laboratory testing, and ongoing safety monitoring during treatment.
Providers say the availability of these medications reflects continued progress in the field of dementia care and offers new possibilities for patients seeking interventions beyond traditional symptom management approaches.
Although the therapies are not considered cures for Alzheimer’s disease, clinicians note that they may help certain patients maintain cognitive function and independence longer than previously possible. The Memory Clinic is among a growing number of centers nationwide bringing emerging Alzheimer’s therapies into clinical practice.
